BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10767598)

  • 1. Evaluation of absorption enhancement for a potent cyclopeptidic alpha(nu)beta(3)-antagonist in a human intestinal cell line (Caco-2).
    Kamm W; Jonczyk A; Jung T; Luckenbach G; Raddatz P; Kissel T
    Eur J Pharm Sci; 2000 May; 10(3):205-14. PubMed ID: 10767598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of permeation enhancers on the transport of a peptidomimetic thrombin inhibitor (CRC 220) in a human intestinal cell line (Caco-2).
    Werner U; Kissel T; Reers M
    Pharm Res; 1996 Aug; 13(8):1219-27. PubMed ID: 8865316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
    Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
    Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells.
    Lindmark T; Kimura Y; Artursson P
    J Pharmacol Exp Ther; 1998 Jan; 284(1):362-9. PubMed ID: 9435199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption.
    Ribadeneira MD; Aungst BJ; Eyermann CJ; Huang SM
    Pharm Res; 1996 Feb; 13(2):227-33. PubMed ID: 8932441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of conjugated linoleic acid and medium-chain fatty acids on transepithelial calcium transport in human intestinal-like Caco-2 cells.
    Jewell C; Cashman KD
    Br J Nutr; 2003 May; 89(5):639-47. PubMed ID: 12720584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodrug approach for alphaIIbbeta3-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): comparison of in vitro and in vivo data.
    Kamm W; Raddatz P; Gante J; Kissel T
    Pharm Res; 1999 Oct; 16(10):1527-33. PubMed ID: 10554093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
    Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
    Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
    Ingels F; Beck B; Oth M; Augustijns P
    Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption properties of micellar lipid metabolites into Caco2 cells.
    Tsuzuki W
    Lipids; 2007 Jul; 42(7):613-9. PubMed ID: 17582542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms.
    Lind ML; Jacobsen J; Holm R; Müllertz A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):261-70. PubMed ID: 17890067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of sodium taurocholate to the absorption of cefquinome.
    Yu Q; Cao Y; Liu LF; Jiang SX; Yang Q
    Pak J Pharm Sci; 2016 Jan; 29(1):139-43. PubMed ID: 26826827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell.
    Mukherjee T; Squillantea E; Gillespieb M; Shao J
    Drug Deliv; 2004; 11(1):11-8. PubMed ID: 15168786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells.
    Brayden DJ; Gleeson J; Walsh EG
    Eur J Pharm Biopharm; 2014 Nov; 88(3):830-39. PubMed ID: 25460147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of paracellular transport of heparin disaccharide across Caco-2 cell monolayers.
    Cho SY; Kim JS; Li H; Shim C; Linhardt RJ; Kim YS
    Arch Pharm Res; 2002 Feb; 25(1):86-92. PubMed ID: 11885699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA.
    Van Gelder J; Witvrouw M; Pannecouque C; Henson G; Bridger G; Naesens L; De Clercq E; Annaert P; Shafiee M; Van den Mooter G; Kinget R; Augustijns P
    Int J Pharm; 1999 Sep; 186(2):127-36. PubMed ID: 10486430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bio-relevant media to assess drug permeability: sodium taurocholate and lecithin combination or crude bile?
    Berginc K; Trontelj J; Kristl A
    Int J Pharm; 2012 Jun; 429(1-2):22-30. PubMed ID: 22449411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
    Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
    Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of absorption enhancers in Caco-2 cell monolayers.
    Sakai M; Imai T; Ohtake H; Otagiri M
    J Pharm Pharmacol; 1998 Oct; 50(10):1101-8. PubMed ID: 9821655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
    Brayden DJ; Walsh E
    AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.